Femasys Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Femasys Inc. (FEMY) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$4.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-14
- Femasys Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$4.47M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $328.65K.
- Femasys Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$3.95M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$4.19M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$18.63M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$18.82M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$14.25M.
- Femasys Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$11.39M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.47M 10-Q · filed 2026-08-14 | -$3.62M 10-Q · filed 2026-08-14 | -$8.09M derived: sum of 3 quarters · filed 2026-08-14 | -$12.29M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $328.65K 10-Q · filed 2026-05-08 | -$3.62M derived: sum of 2 quarters · filed 2026-05-08 | -$7.82M derived: sum of 3 quarters · filed 2026-05-08 | -$12.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.15M derived: sum of 2 quarters · filed 2026-03-31 | -$12.73M derived: sum of 3 quarters · filed 2026-08-14 | -$18.63M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$4.19M 10-Q · filed 2025-11-14 | -$8.78M derived: sum of 2 quarters · filed 2026-08-14 | -$14.68M 10-Q · filed 2025-11-14 | -$19.80M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$4.59M 10-Q · filed 2026-08-14 | -$10.48M 10-Q · filed 2026-08-14 | -$15.61M derived: sum of 3 quarters · filed 2026-08-14 | -$21.02M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$5.90M 10-Q · filed 2026-05-08 | -$11.02M derived: sum of 2 quarters · filed 2026-05-08 | -$16.43M derived: sum of 3 quarters · filed 2026-05-08 | -$21.11M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$10.53M derived: sum of 2 quarters · filed 2026-03-31 | -$15.22M derived: sum of 3 quarters · filed 2026-03-31 | -$18.82M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$5.41M 10-Q · filed 2025-11-14 | -$10.09M derived: sum of 2 quarters · filed 2025-11-14 | -$13.69M 10-Q · filed 2025-11-14 | -$18.10M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$4.68M 10-Q · filed 2025-08-08 | -$8.28M 10-Q · filed 2025-08-08 | -$12.69M derived: sum of 3 quarters · filed 2025-08-08 | -$16.69M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$3.60M 10-Q · filed 2025-05-08 | -$8.01M derived: sum of 2 quarters · filed 2025-05-08 | -$12.01M derived: sum of 3 quarters · filed 2025-05-08 | -$14.90M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$8.41M derived: sum of 2 quarters · filed 2025-03-27 | -$11.30M derived: sum of 3 quarters · filed 2025-03-27 | -$14.25M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$4.00M 10-Q · filed 2024-11-12 | -$6.89M derived: sum of 2 quarters · filed 2024-11-12 | -$9.84M 10-Q · filed 2024-11-12 | -$12.73M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$2.89M 10-Q · filed 2024-08-08 | -$5.84M 10-Q · filed 2024-08-08 | -$8.73M derived: sum of 3 quarters · filed 2024-08-08 | -$11.72M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.95M 10-Q · filed 2024-05-09 | -$5.84M derived: sum of 2 quarters · filed 2024-05-09 | -$8.82M derived: sum of 3 quarters · filed 2024-05-09 | -$11.46M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$5.88M derived: sum of 2 quarters · filed 2024-03-28 | -$8.51M derived: sum of 3 quarters · filed 2024-03-28 | -$11.39M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$2.98M 10-Q · filed 2023-11-14 | -$5.62M derived: sum of 2 quarters · filed 2023-11-14 | -$8.50M 10-Q · filed 2023-11-14 | -$10.86M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$2.63M 10-Q · filed 2023-08-10 | -$5.52M 10-Q · filed 2023-08-10 | -$7.88M derived: sum of 3 quarters · filed 2023-08-10 | -$10.14M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$2.88M 10-Q · filed 2023-05-11 | -$5.25M derived: sum of 2 quarters · filed 2023-07-24 | -$7.51M derived: sum of 3 quarters · filed 2023-07-24 | -$8.59M derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | -$2.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | -$4.62M derived: sum of 2 quarters · filed 2023-07-24 | -$5.71M derived: sum of 3 quarters · filed 2023-07-24 | -$7.54M 10-K/A · filed 2023-07-24 |
| 2021-09-30 | -$2.26M 10-Q · filed 2022-11-10 | -$3.34M derived: sum of 2 quarters · filed 2022-11-10 | -$5.17M 10-Q · filed 2022-11-10 | -$6.83M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.08M 10-Q · filed 2022-08-10 | -$2.91M 10-Q · filed 2022-08-10 | -$4.57M derived: sum of 3 quarters · filed 2022-08-10 | -$6.14M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$1.83M 10-Q · filed 2022-05-11 | -$3.49M derived: sum of 2 quarters · filed 2022-05-11 | -$5.06M derived: sum of 3 quarters · filed 2022-05-11 | -$6.54M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$3.23M derived: sum of 2 quarters · filed 2022-03-24 | -$4.71M derived: sum of 3 quarters · filed 2022-03-24 | -$6.91M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$1.57M 10-Q · filed 2021-11-12 | -$3.05M derived: sum of 2 quarters · filed 2021-11-12 | -$5.26M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$1.49M 10-Q · filed 2021-08-11 | -$3.69M 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |